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Population studies elucidating the genetic architecture of reproductive ageing have been
largely limited to European ancestries, restricting the generalizability of the findings and
overlooking possible key genes poorly captured by common European genetic variation. Here,
we report 26 loci (all P < 5 × 10–8) for reproductive ageing, i.e. puberty timing or age at
menopause, in a non-European population (up to 67,029 women of Japanese ancestry).
Highlighted genes for menopause include GNRH1, which supports a primary, rather than
passive, role for hypothalamic-pituitary GnRH signalling in the timing of menopause. For
puberty timing, we demonstrate an aetiological role for receptor-like protein tyrosine phos-
phatases by combining evidence across population genetics and pre- and peri-pubertal
changes in hypothalamic gene expression in rodent and primate models. Furthermore, our
findings demonstrate widespread differences in allele frequencies and effect estimates
between Japanese and European associated variants, highlighting the benefits and challenges
of large-scale trans-ethnic approaches.
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The first menstrual period (‘menarche’) and onset ofmenopause are key milestones of female reproductiveageing, representing the start and end of reproductive
capacity. The timings of these events vary widely between indi-
viduals and are predictors of the rate of ageing in other body
systems1. This variation reflects a complex mix of genetic and
environmental factors that population-based studies are begin-
ning to unravel. Over the past decade, successive waves of
genome-wide association study (GWAS) meta-analyses have
illuminated the genetic architecture of reproductive ageing and
shed light on several underlying biological processes, many of
which are also highlighted through studies of rare human dis-
orders of reproduction2–7. Hence, puberty timing appears to be
predominantly regulated by the central nervous system, including
components of the hypothalamic–pituitary axis and complex
molecular silencers of that system5. In contrast, the aetiological
drivers of menopause timing appear to be ovary-centric, largely
focussed on the ability of oocytes to maintain genome stability
and hence preserve the ovarian primordial follicle pool7.
A key limitation of previous GWAS for reproductive ageing is
their large circumscription to populations of European ancestry,
due to the lack of available large-scale studies of other populations.
This population restriction has limited the generalizability of the
findings and may have led to a failure to detect key genes and
pathways that are poorly represented by common functional
variants in European populations. Previous small-scale genetic
studies in East Asian and African–American samples have repli-
cated a small number of the reported European loci8–10. However,
such studies have not yet demonstrated any known or new genetic
association signals for menarche or menopause timing at genome-
wide statistical significance. To address this limitation, here we
describe two separate GWAS for ages at menarche and menopause
in up to 67,029 women of Japanese ancestry from the BioBank
Japan (BBJ) Project11. This sample represents a threefold larger
sample size than any previous non-European ancestry GWAS9.
We identify 26 loci for ages at menarche or menopause at
genome-wide significance, implicating several new genes and
pathways. The analyses also reveal widespread differences in effect
estimates between populations, highlighting the benefits and
challenges of trans-ethnic GWAS meta-analyses.
Results
Effects of previously reported European loci in Japanese. Data
on age at natural menopause and age at menarche were available
for 43,861 and 67,029 genotyped women of Japanese ancestry,
respectively (Supplementary Table 1). Genotyping array-based
heritability in this Japanese sample was 10.4% (S.E. 0.9%) for
menopause (contrasting with 36% in Europeans) and 13% (S.E.
0.6%) for menarche (32% in Europeans). Mean age at menarche in
this Japanese population (overall: 13.9 years) was higher than
previously reported in contemporary European populations
(12.4–13.7 years)5, but showed a marked secular trend in Japanese
from 15.2 years in women born pre-1935 to 12.3 years in those
born post-1965, and this was accompanied by increasing herit-
ability (from 14.2% to 20.6%; Phet= 0.03, Supplementary Table 2).
Of the 54 previously identified European menopause loci
(Supplementary Data 1), 52 were polymorphic in Japanese; of
these 46 (88.4%) had a consistent direction of effect (binomial P
= 1 × 10−8; 29 loci at nominal significance P < 0.05). For
menarche, 348/377 autosomal variants found in Europeans were
present in the Japanese dataset (Supplementary Data 2); of these
282/348 (81.0%) had a consistent direction of effect (binomial P
= 6.4 × 10−33, 108 loci at P < 0.05). In aggregate, genetic
variation ± 250 kb from European-identified SNPs explained 2%
(S.E. 0.2%) and 3.6% (S.E. 0.2%) of the trait variance for age at
menopause and menarche, respectively (contrasting with 8.0%
[S.E. 0.5%] and 8.4% [S.E. 0.4%] in Europeans, respectively).
There were notable differences in allele frequencies between
populations at these European-identified signals (Supplementary
Data 1), with 23 loci (2 menopause, 21 menarche) monomorphic
in Japanese. The mean absolute difference in allele frequency was
17%, with the largest difference at the menarche locus, 20q11.21,
where the C-allele at rs1737894 in Europeans (frequency ~60%) is
absent in Japanese.
To compare effect sizes between populations at these
previously identified signals, we calculated effect estimates for
Europeans in up to 73,397 women from the UK Biobank study,
independent of the European discovery samples. Across 52
(polymorphic in Japanese) menopause loci, 44 (84.6%)
showed a larger effect in Europeans than in Japanese (binomial
P= 4 × 10−7), 23 of which were significantly different
(Pdiff < 0.05, Supplementary Data 1). Similarly, for the 102
menarche loci that were previously identified in Europeans
excluding UK Biobank (Supplementary Data 3), 77 (75.5%)
showed larger effects in UK Biobank Europeans than in Japanese
(binomial P= 2.5 × 10−7, 22 at Pdiff < 0.05). We were able to
compare our Japanese allele frequencies and effect estimates to
Chinese data for a subset of known European loci from a recent
study10. For both menarche and menopause there was high
concordance in both allele frequency (minimum r2= 0.95,
Supplementary Figure 1) and effect estimates (r2= 0.5,
Supplementary Figure 2).
In aggregate, our findings likely indicate widespread population
differences in LD between GWAS signals and the underlying
causal variants, or possible differences in modifying environ-
mental factors.
Menopause and menarche signals in Japanese. To identify
genetic signals for ages at menopause and menarche in our
Japanese population, we tested genome-wide markers imputed to
the 1000 genomes Phase 3 reference panel12. For menopause,
16 independent signals reached genome-wide significance
(P < 5 × 10−8), 8 of which are novel and not previously reported in
Europeans (Table 1; Fig. 1). Additionally, we found a signal
(rs76498344, PJapanese= 3.6 × 10−12) near the previously reported
locus MCM8 which was uncorrelated with the reported European
lead SNP (rs451417, PJapanese= 0.002, r2= 0.03 with rs76498344
in Japanese) and showed no association in Europeans (rs76498344
PEuro= 0.78)5. Formal conditional analysis confirmed the inde-
pendence of these two signals (Punadjusted= 3.6 × 10−12, betau-
nadjusted= 0.22 Padjusted for rs451417= 1.7 × 10−10, betaadjusted= 0.20).
For menarche, 10 independent signals reached genome-wide
significance, two of which are novel loci, and a third represents a
novel Japanese-specific signal in a known European locus (r2~0)
near PTPRD (Table 1; Fig. 1). To evaluate the effect of BMI as a
potential confounder, we tested the association of all significant
loci with additional adjustment of BMI at recruitment. There was
no appreciable attenuation of test statistic observed at any of the
loci (Supplementary Data 4), indicating that these variants exert
their effects through pathways independent of adiposity.
Of the 12 novel signals for the two traits, 5 showed larger effect
sizes in Japanese than in Europeans (Pheterogeneity < 0.004; i.e.=
0.05/12; Table 1). A further three signals were likely not identified
in previous GWAS due to markedly lower allele frequencies in
Europeans: EIF4E (rs199646819, minor allele frequency (MAF) in
Japanese vs. Europeans: 39 vs. 2%), NKX2-1 (rs2076751: 25 vs.
7%) and THOC1 (rs77001758: 40 vs. 0.1%). In a meta-analysis
allowing for trans-ethnic heterogeneity, 10 of the 12 signals
remained genome-wide significant when combined with Eur-
opean data (Supplementary Data 4).
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Four novel signals were highly correlated (r2 > 0.7) with missense
variants, implicating the genes GNRH1, HMCES, ZCCHC2 and
ZNF518A in the regulation of menopause timing. Notably, rs6185
(Trp16Ser) in GNRH1 is exactly the same lead SIFT-predicted
deleterious missense variant recently reported for age at menarche
in Europeans5. In our Japanese sample, the rs6185 G-allele was
associated with later menopause (beta= 0.19 years per allele,
P= 3 × 10−13) and later menarche (P= 3.5 × 10−5), but it
reportedly has no effect on menopause timing in Europeans
(beta= 0.03 years per allele, P= 0.16, N= 67,602). HMCES at
3q21.3 encodes an embryonic stem cell-specific binding protein for
5-hydroxymethylcytosine, a recently described epigenetic modifica-
tion that is dynamically regulated during oocyte ageing13,
while ZNF518A at 10q24.1 encodes an interaction partner of
the epigenetic silencing machineries G9a/GLP and Polycomb
Repressive Complex 214.
Biological processes, tissues and cell type enrichment. We next
sought to systematically test which biological processes, tissues
and cell types were most represented by genetic variation
associated with menarche and menopause. Firstly, genome-
wide pathway analyses were performed using MAGENTA
(Methods). A total of 13 pathways were significant after mul-
tiple test correction, all for age at menopause. These results
recapitulated previously observed associations in Europeans5,7,
particularly highlighting DNA damage response mechanisms
(Supplementary Data 5 and 6). Secondly, we identified sig-
nificantly enriched cell and tissue types using two approaches –
MAGMA and LDSC-SEG (Methods). Again, these results were
broadly consistent with observations from larger European
datasets, highlighting particular enrichment with all three
components of the hypothalamic–pituitary–ovarian axis (Sup-
plementary Table 3 and Supplementary Figure 3). Finally, we
integrated both gene expression and methylation data at the
level of individual loci. Using human RNA-seq data from the
GTEx project, we focused enrichment analyses on the three
components of the HPG-axis (Supplementary Data 7 and 8).
This highlighted one gene for menarche (LIN28B) and three for
menopause (NRB2, LY6G5C and BAG6). Methylation data were
only available in whole blood, where integration identified 101
CpG sites significantly associated with menarche or menopause
(Supplementary Data 9).
Genetic associations with early or late menarche timing. As was
recently shown in Europeans5, we tested in our Japanese GWAS
sample whether variants associated with continuous age at
menarche have disproportionately larger effects on early vs. late
puberty timing in females. The approximate earliest (9–12 years
Table 1 Genome-wide significant signals identified for ages at menarche and menopause in the BioBank Japan Project
Location SNP (r2)a Allelesb Nearest Gene Japanese (BBJ) European samples Het. P
Effect (S.E) P Effect (S.E) P
Novel signals at novel loci
Menopause
3q21.3 rs4853 T/C/0.94/0.90 H1FX 0.48 (0.05) 2E−18 0.03 (0.05) 5E−01 2E−09
4p11 rs10049761 T/G/0.36/0.50 ZAR1 0.22 (0.03) 2E−15 0.08 (0.03) 4E−03 1E−03
4q23 rs199646819 A/ATGG/0.61/0.02 EIF4E 0.15 (0.03) 3E−08 0.19 (0.11) 7E−02 7E−01
8p21.2 rs6185 G/C/0.51/0.25 GNRH1 0.19 (0.03) 3E−13 0.04 (0.04) 3E−01 7E−04
8q24.11 rs2921759 T/C/0.82/0.98 RAD21 0.19 (0.03) 2E−08 −0.11 (0.12) 4E−01 1E−02
10q24.1 rs1889921 T/G/0.53/0.53 CCNJ 0.24 (0.03) 2E−20 0.11 (0.03) 1E−04 7E−04
14q24.2 rs8010674 C/T/0.63/0.62 DCAF4 0.15 (0.03) 3E−08 0.07 (0.03) 3E−02 5E−02
18q21.33 rs200296776 C/T/0.99/0.999 ZCCHC2 1.15 (0.20) 9E−09 −0.63 (1.69) 6E−01 3E−01
Menarche
14q13.3 rs2076751 C/A/0.75/0.93 NKX2-1 0.07 (0.01) 1E−11 0.07 (0.02) 3E−05 9E−01
18p11.32 rs77001758 A/G/0.40/0.001 THOC1 0.05 (0.01) 5E−09 0.32 (0.15) 4E−02 8E−02
Novel signals at known loci
Menopause
20p12.3 rs76498344 (0.03) C/T/0.23/0.05 MCM8 0.22 (0.03) 4E−12 0.01 (0.07) 8E−01 7E−03
Menarche
9p23 rs291269 (0) G/A/0.37/0.32 PTPRD 0.05 (0.01) 2E−08 0.01 (0.01) 3E−01 9E−04
Genome-wide significant signals correlated with known European signals
Menopause
4q21.23 rs7665103 (0.97) G/A/0.62/0.41 HELQ 0.15 (0.03) 4E−08 0.25 (0.03) 5E−17 1E−02
5q35.2 rs34933909 (0.91) T/G/0.49/0.45 UIMC1 0.20 (0.03) 9E−14 0.32 (0.03) 2E−26 4E−03
6p24.2 rs12211124 (0.22) T/C/0.69/0.64 SYCP2L/MAK 0.20 (0.03) 2E−12 0.16 (0.03) 1E−07 4E−01
6p21.33 rs28474889 (0.41) C/T/0.73/0.80 MSH5/HLA 0.24 (0.03) 5E−16 0.16 (0.04) 4E−06 1E−01
8p12 rs28807105 (0.30) G/A/0.30/0.22 EIF4EBP1 0.16 (0.03) 2E−08 0.43 (0.04) 6E−32 6E−09
12q13.3 rs2277339 (1) T/G/0.80/0.89 PRIM1/TAC3 0.29 (0.03) 7E−20 0.33 (0.05) 1E−11 5E−01
17q21.31 rs8176071 (0.98) GTGT/G/0.34/0.33 BRCA1 0.16 (0.03) 1E−08 0.15 (0.03) 3E−06 8E−01
Menarche
1q23.3 rs78408536 (0.60) CT/C/0.72/0.86 RXRG 0.05 (0.01) 5E−08 0.07 (0.01) 6E−09 4E−01
2q33.1 rs35020808 (0.88) GT/G/0.50/0.68 SATB2 0.06 (0.01) 5E−11 0.05 (0.01) 7E−07 2E−01
6q16.3 rs11285463 (1) AT/A/0.29/0.45 LIN28B 0.08 (0.01) 3E−16 0.11 (0.01) 5E−42 2E−02
8q21.11 rs7821604 (1) C/G/0.51/0.85 ZFHX4 0.05 (0.01) 2E−08 0.03 (0.01) 7E−03 2E−01
9q31.2 rs1516883 (0.91) G/A/0.53/0.69 TMEM38B 0.06 (0.01) 4E−12 0.12 (0.01) 5E−39 2E−05
11q24.1 rs144048300 (0.26) T/A/0.16/0.10 C11orf63 0.07 (0.01) 1E−08 0.05 (0.01) 2E−04 4E−01
14q32.2 rs142252570 (1) CTAAT/C/0.82/0.95 – 0.07 (0.01) 2E−09 0.09 (0.02) 1E−06 3E−01
Associations with menarche/menopause were analysed in 67,029/43,861 Japanese (BBJ) and 73,397/32,545 European (UK Biobank) women
ar2 between Japanese and European reported lead SNP calculated in Japanese
bEffect allele/Other allele/Effect allele frequency (EAF) in Japanese/Europeans
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inclusive: N= 15,709) and latest (16–20 years: N= 10,875) strata
of age at menarche in Japanese were each compared to the same
reference group (14 years: N= 14,557). Consistent with findings
in Europeans5, in Japanese more variants had larger effects on
early than on late menarche timing (Supplementary Data 11,
55.7%, 191/343, binomial P= 0.02).
We then tested variants genome-wide for early or late
menarche timing in Japanese. We identified just one signal at
P < 5 × 10−8, rs10119582 near PTPRD associated with
early menarche timing (C-allele: OR 1.17 [1.12–1.23],
P= 8.9 × 10−13), which was partially correlated with the novel
signal for continuous age at menarche in Japanese (r2= 0.31 with
rs291269) and the known European menarche signal at this
region (r2= 0.11 with rs10959016) (Fig. 2a). Re-analysis of the
early menarche model for rs10119582 conditioned on those two
other SNPs showed no appreciable change to the magnitude of
effect (Supplementary Data 11, beta was attenuated by 13%,
conditional P= 3.3 × 10−7). An examination of rs10119582 by
each completed whole year of menarche showed that its effects
were confined to those ages earlier than the median (age 14),
without any apparent effect on menarche timing when older than
the median age (Fig. 2b).
Receptor-like protein tyrosine phosphatase genes. Receptor-like
protein tyrosine phosphatases (PTPRs) are a family of 20 cell-
surface proteins with intracellular phosphotyrosine phosphatase
activity15. In addition to the 2 Japanese-specific signals at PTPRD,
for continuous and early age at menarche, in Europeans 6 further
independent signals have been described for menarche (in/near:
PTPRD, PTPRF, PTPRJ, PTPRK, PTPRS and PTPRZ1) with 2
others just short of genome-wide significance (P < 6 × 10−8, in/
near: PTPRG and PTPRN2). In combination, this gene family is
enriched for variant associations with age at menarche
(MAGENTA pathway enrichment PEuro= 7 × 10−3).
To explore the role of the PTPR gene family in the
physiological regulation of puberty timing, we examined changes
in gene expression, assessed by RNA-sequencing, in rat medial
basal hypothalamus at 5 time points from infancy (postnatal days,
PND7 and 14), through juvenile development (EJ, early juvenile
PND21; LJ, late juvenile PND28), to the peripubertal period (LP,
day of the preovulatory surge of gonadotropins). In false
discovery rate-corrected analyses, 13 of the 20 PTPR genes
examined were differentially expressed over time: 6 genes were
upregulated (PTPRB, PTPRC, PTPRJ, PTPRM, PTPRN and
PTPRN2) (all FDR < 0.014), and 7 genes were downregulated
(PTPRD, PTPRG, PTPRK, PTPRO, PTPRS, PTPRT and PTPRZ1)
(Fig. 3a, b; Supplementary Table 4). Additional examination of
medial basal hypothalamus expression in a primate model,
assessed by quantitative PCR of selected PTPR genes, showed
similar time trends in expression as seen in rat hypothalamus:
expression of PTPRN was up-regulated and PTPRZ was down-
regulated from infancy through puberty (Fig. 3c).
Discussion
Our study represents a large non-European ancestry genomic
analysis for reproductive ageing, identifying genome-wide sig-
nificant loci for ages at menarche and menopause in an
East Asian population. While the overall heritability estimates
were lower in Japanese than in European ancestry populations,
we present to our knowledge the first evidence for a secular trend
in the heritability for any non-behavioural trait. Secular trends
towards earlier age at menarche are widely reported16 and are
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Fig. 1 ‘Miami’ plot showing genome-wide association test statistics for ages at menarche (top) and menopause (bottom) in the BioBank Japan Project.
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accompanied by secular declines in its variance17 – our findings
may suggest that such changes may be explained by declining
population variability in exposure to environmental factors that
delay puberty, such as childhood undernutrition18. Despite these
population differences in heritability, our findings support a
largely shared genetic architecture of reproductive ageing, notably
with the replication at genome-wide significance in Japanese of 14
known European signals for menarche or menopause (Table 1).
However, both effect allele frequencies and effect estimates varied
considerably between populations, likely due to a combination of
differential genetic drift, selection, recombination and possibly
also environmental setting, resulting in substantial heterogeneity
in genetic associations between the population groups and rein-
forcing the need to appropriately model such trans-ethnic dif-
ferences in meta-analyses.
Such differences in genetic architecture underpin the value of
studying genetic associations in diverse population groups to
identify novel signals. Hence, even in a Japanese dataset con-
siderably smaller than the largest reported European meta-
analysis5, we identified 10 novel loci for ages at menarche or
menopause, and these findings implicated novel genes and
pathways as involved in human reproductive ageing. In addition
to HMCES and ZNF518A described above, at the novel menarche
locus at 14q13.3, the nearest gene NKX2-1, encodes a home-
odomain gene that is required for basal forebrain morphogenesis
and also remains active in the adult nonhuman primate hypo-
thalamus, where its ablation in mice results in delayed puberty,
reduced reproductive capacity, and a short reproductive span19,
but, until now, has not been implicated in human reproductive
function. At the novel menopause locus at 4q23, the nearest gene
EIF4E encodes a key translation initiation factor; EIF4E is the
target of the inhibitory binding protein encoded by EIF4EBP1,
which is near to a known European ancestry menopause locus7,
while a rare deleterious stop mutation in EIF4ENIF1, which
encodes a nucleocytoplasmic shuttle protein for EIF4E, segregates
with primary ovarian insufficiency (menopause at ~30 years old)
in a large kindred20. Other novel menopause loci implicate: the
evolutionarily conserved maternal-effect gene ZAR1, which
encodes an oocyte-specific protein that is critical for oocyte-to-
embryo transition21; H1FX, which encodes a member of the
histone H1 family; and RAD21, a gene involved in chromatid
cohesion during mitosis and the repair of DNA double-strand
breaks, and mutated in two children with Cornelia de Lange
syndrome-4, a complex disorder with cellular characteristics of
decreased chromatid separation, increased aneuploidy and
defective DNA repair22. Ultimately, functional work in various
cellular and animal models will be required to explore all of our
highlighted genomic associations in more detail and fully eluci-
date the pathway linking DNA sequence variation to phenotypic
consequence.
Our identification of a deleterious variant rs6185 (Trp16Ser) in
GNRH1, a known signal for age at menarche, as a novel locus for
menopause timing suggests an unexpected primary role of
hypothalamo-pituitary GnRH signalling in the onset of meno-
pause. Typically, menopause is characterized by ovarian failure
and accompanied by a secondary (presumed passive) rise in
GnRH-driven gonadotropin secretion. Our finding that the
rs6185 G-allele, which delays menarche, also delays menopause is
consistent with similar reported effects of alleles near FSHB23,24,
and together suggest that lower levels of gonadotropin secretion
may extend reproductive lifespan. Alternatively, GnRH receptor
mRNA has been recognized in human ovary, where it may
mediate reported autocrine/paracrine actions of GnRH to induce
apoptosis of ovarian granulosa cells25. Interestingly, despite
consistent associations between rs6185 and menarche timing in
both Japanese and Europeans, which argues against population
differences in LD with an unseen causal variant, we saw a fivefold
greater effect of rs6185 on menopause timing in Japanese than
Europeans, a difference that suggests some yet identified strong
environmental modification. Future studies, both within popu-
lations and across populations, should seek to comprehensively
assess environmental modifiers at the level of individual loci and
overall heritability.
Finally, we provide multiple sources of evidence in support of a
role for receptor-like protein tyrosine phosphatases (PTPRs) in
the regulation of puberty timing, spread across most of the 8
PTPR sub-types (summarized in Table 2). The PTPRs are
involved in important developmental processes, including the
formation of the nervous system by controlling axon growth and
guidance15. Inactivation of Ptprs in the mouse is reported to
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result in hyposmia and structural defects in the hypothalamus
and pituitary26. Directly relevant to the regulation of pubertal
timing is the observation that in prepubertal female mice a short
isoform of PTPRZ1 (also known as RPTPβ) expressed in astro-
cytes interacts with the glycosylphosphatidyl inositol-anchored
protein contactin expressed in GnRH neurons27. Because con-
tactin is particularly abundant in GnRH nerve terminals, it has
been postulated that GnRH neuron-astrocyte communication is
in part mediated by RPTPβ-contactin interactions during female
reproductive development27. Collectively, our human genomic
data in European and Japanese datasets, in addition to these
animal models suggest that PTPRs are involved in the regulation
of puberty timing. Additional functional work, particularly link-
ing our identified sequence variation to PTPR function in
humans, is required to help further understand the role this gene
family plays in pubertal regulation.
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Fig. 3 Changes in hypothalamic PTPR gene expression during prepubertal development of female rats and rhesus monkeys. a PTPR mRNA levels in the
medial basal hypothalamus (MBH) of pre– and peripubertal female rats assessed by massively parallel sequencing (n= 4 biological replicates per
developmental stage). b mRNA abundance of two selected Ptpr genes (Ptprz and Ptprn) in the MBH of pre- and peripubertal female rats assessed by qPCR.
Both the long and short forms of Ptprz are shown. *P < 0.05; **P < 0.01 and ***P < 0.001 vs. PND 7, one-way ANOVA followed by Student-Newman-Keuls
(SNK) multiple comparison test, n= 6–8 rats per group. INF= infantile period (PND7 and PND14); EJ= early juvenile (PND21); LJ= late juvenile (PND28);
LP= late puberty (day of the first preovulatory surge of gonadotropins). c PTPRZ and PTPRN mRNA levels in the MBH of pre– and peripubertal female
rhesus monkeys. *P < 0.05 and ***P < 0.001 vs. infantile (INF) group, one-way ANOVA followed by SNK multiple comparison test, n= 4–8 monkeys per
group. INF= infantile (1–6 months of age); JUV= juvenile (6–19 months of age); PUB= pubertal (24–36 months of age; defined by the presence of
elevated plasma LH levels). Bars represents the mean ± s.e.m
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Methods
BBJ participants and phenotyping. All participants were recruited from Biobank
Japan (BBJ), which is a patient-oriented biobank established in Japan11. The study
protocol was approved by the research ethics committees of the Institute of Medical
Science, the University of Tokyo, the RIKEN Yokohama institute and cooperating
hospitals. Written informed consent was obtained from all participants.
Approximately 200,000 patients diagnosed with any of the 47 targeted common
diseases were enroled in BBJ between 2003 and 2008, and DNA, serum and clinical
information were collected from each patient via 66 hospitals across Japan. The
current analysis was based on 69,616 female participants who provided informa-
tion on either age at menarche or menopause and had genotype data available.
Ages at menarche or menopause were recalled to the nearest whole completed year
at baseline and at multiple follow-up visits. Participants were excluded based on the
following conditions: (i) missing age at menarche or menopause; (ii) missing age at
recruitment; (iii) maximum difference in the recalled ages at menarche or meno-
pause collected on multiple visits >5 years; (iv) age at recruitment was younger
than reported age at menarche or menopause; (v) missing birth year (for analyses
of age at menarche); (vi) age at menarche <9 or >20 years; (vii) age at menopause
<40 or >60 years and (vii) patients with medical history of hysterectomy, ovar-
iectomy, radiation, chemotherapy and hormone replacement treatment (for ana-
lyses of age at menopause). Where age at menarche or menopause was reported at
multiple visits, mean values for each were calculated. In total, 67,029 participants
with age at menarche and 43,861 with age at menopause were included in the
quantitative trait analyses. Age at menarche was also stratified into ‘early’ (ages
9–12 years inclusive, N= 15,709) and ‘late’ (ages 16–20 years inclusive, N=
10,875), and each of these two groups was compared to the same median reference
group (age 14, N= 14,557).
Genotype QC imputation and discovery GWAS analysis. BBJ participants had
DNA genotyped on more than 950,000 variants using either (a) a combination of
Illumina Human OmniExpress BeadChip and Infinium HumanExome BeadChip
or (b) Infinium OmniExpressExome BeadChip alone. Variants overlapping across
these two sets of genotyping arrays were extracted. Variants were then excluded
according to the following criteria: (i) monomorphic in any chip; (ii) call rate
<99%; (iii) minor allele count in heterozygotes <5; (iv) Hardy-Weinberg Equili-
brium P-value <1 × 10−6 in any chip. For sample quality control, we excluded
samples with (i) call rate <98%; (ii) discordant phenotypic and genotypic sex; (iii)
excess heterozygosity; (iv) cryptic relatedness assessed by pi_hat measurement
(>0.2) for identity by descent; or if (v) not from mainland Japan identified by
principal component analysis using all samples from the 1000 Genomes Project12.
After quality control, 532,488 autosomal variants were phased using Eagle228 and
subsequently imputed up to the reference panel from the 1000 Genomes Project
Phase 3 using minimac329.
Variants with good imputation quality (minimac rsq >0.3)30 were tested for
associations with two quantitative traits, age at menarche and age at menopause,
and two dichotomous traits, early menarche and late menarche, assuming additive
allelic effects. Associations with ages at menarche and menopause were tested in
linear regression models using mach2qtl31. Associations with early and late
menarche (both vs. the median group), or each age year of age at menarche (age 9,
10, 11, 12, 13, 15, 16, 17, 18, 19 and 20) vs. the same median (age 14) group), were
tested in logistic regression models using mach2dat31. In each model, ten principal
components were included to adjust for cryptic population structure, in addition to
birth year as a covariate.
Variance explained by genetic variants in the current study were estimated
using the Restricted Estimate Maximum Likelihood (REML) method implemented
in BOLT-LMM32. We tested different SNP sets: (i) Directly genotyped variants
within 250 kb up- or down-stream of the previously reported European lead
variants5,7, and (ii) all directly genotyped variants which passed quality control.
The same methodology and default parameters were applied to both the BBJ and
UK Biobank study, using ancestry-specific LD scores generated from the 1000
Genomes project. Pathway enrichment was performed on 3216 pathways defined
in Gene Ontology, PANTHER, KEGG and Ingenuity using MAGENTA33. The
same approach was used to test the set of 20 PTPR family genes. All default
parameters were used, and significance was based on an FDR<0.05 for the 75th
enrichment centile.
Gene expression integration. Tissue enrichment analyses were performed using
MAGMA34 (implemented through FUMA35) and LDSC-SEG36. Software supplied
default parameters were used for both approaches, and East-Asian specific LD
scores and LD information were used where appropriate. Tissue enrichment was
performed on tissues from the V6p GTEx release. Individual locus expression and
methylation data were incorporated using Summary Mendelian Randomization
(SMR)37. We used a subset of 1344 unrelated East Asian individuals (based on
principle component analysis and self-reported ancestry) from the UK Biobank
study (500 K HRC release) as an LD reference panel for SMR analysis. Analysis was
performed using the pre-supplied McRae et al. methylation data and V7 GTEx
gene expression data (http://cnsgenomics.com/software/smr/#Download). All
analyses used a Bonferroni correction based on the number of tests performed (i.e
0.05/N genes).
Effect estimate comparisons with European-ancestry samples. Known
menarche and menopause European loci were defined as those discovered in the
two largest reported GWAS meta-analyses to date5,7. As effect estimates reported
in discovery meta-analyses are potentially inflated due to the ‘winners curse’
phenomenon, we derived more robust European effect estimates in independent
samples from the UK Biobank study38. For menarche, this required us to restrict
the number of known European loci to the largest discovery meta-analysis prior to
inclusion of UK Biobank5. A total of 73,397 women with genotype and age at
menarche were available from UK Biobank5. Age of natural menopause was
available for 32,545 UK Biobank women, using the same inclusion/exclusion cri-
teria applied to BBJ women. This analysis was performed using a linear mixed
model implemented in BOLT39. Trans-ethnic meta-analysis was performed using
Han and Eskin’s Random Effects model, implemented in Metasoft40.
Animal samples for hypothalamic gene expression. Sprague Dawley female rats
were studied at different phases of postnatal development: infantile postnatal day
(PND) 7 and 14, early juvenile (EJ) PND21, late juvenile (LJ) PND28 and late
puberty (LP, the day of the first preovulatory surge of gonadotropins, PND32–38.
The use of rats was approved by the ONPRC Animal Care and Use Committee in
accordance with the NIH guidelines for the use of animals in research. The animals
were obtained from Charles River Laboratories international, Inc. (Hollister, CA),
and were housed in a room with controlled photoperiod (12/12 h light/dark cycle)
and temperature (23–25 °C). They were allowed ad libitum access to pelleted rat
chow and water. The medial basal hypothalamus (MBH) of female rats was col-
lected at various postnatal ages as described41. The tissues were frozen on dry ice
and stored at −85 °C before RNA extraction.
Female rhesus monkey (Macaca mulatta) hypothalamic tissue samples were
obtained through the Oregon National Primate Research Center (ONPRC) Tissue
Distribution Program for the studies of infantile-pubertal (INF-PUB) transitions.
The animals were classified into different stages of development based on their age
and pubertal stages, following the recommendation reported by Watanabe and
Terasawa42. These developmental stages were: (1) Infantile (3–6 months of age,
characterized by relatively elevated plasma LH levels, and immature aspect of the
external genitalia; (2) Juvenile (between 6–20 months of age), characterized by low
plasma LH levels, and an absence of external signs of puberty; and (3) pubertal
(24–44 months of age), characterized by increased plasma LH levels, initiation of
menstruation, and appearance of sex-skin colour changes, without evidence of
ovulation. The brain was removed from the cranium and the MBH was dissected as
previously reported43. The tissues fragments were then snap-frozen in liquid
nitrogen and stored at −80 °C.
RNA extraction and reverse transcription PCR. Total RNA was extracted from
the MBH tissues of female rats and rhesus monkeys at different developmental stages
using the RNeasy mini kit (Qiagen, Valencia, CA) following the manufacturer’s
protocol. DNA contamination was removed from the RNA samples by on-column
digestion with DNAse using the Qiagen RNase-free DNase kit (Qiagen, Valencia, CA)
according to the manufacturer’s instructions. RNA concentrations were determined
by spectrophotometric trace (Nanodrop, ThermoScientific, Wilmington, DE). Five-
hundred ng of total RNA were transcribed into cDNA in a volume of 20 µl using 4 U
of Omniscript reverse transcriptase (Qiagen, Valencia, CA).
Relative mRNA abundance was determined using the SYBR GreenER™ qPCR
SuperMix system (Invitrogen, Carlsbad, CA). Suitable amplification primers were
designed using the PrimerSelect tool of DNASTAR 14 software (Madison, WI) or
the NCBI online Primer-Blast program (Supplementary Table 5). PCR reactions
were performed in a volume of 10 μl containing 1 μl of diluted cDNA, 5 μl of SYBR
GreenER™ qPCR SuperMix and 4 μl of primers mix (1 µM of each gene specific
Table 2 Summary of Receptor-like protein tyrosine
phosphatase (PTPR) genes implicated in the regulation of
puberty through Japanese and European genome-wide
association studies (GWAS) for age at menarche, and pre-
and peri-pubertal changes in hypothalamic gene expression
PTPR sub-
type
Genesa GWAS Expression-up Expression-
down
I C C
IIA D,F,S D,F,S D,S
IIB K,M,U,T K M K,T
III B,H,J,O,Q J B,J O
IV A,E
V G,Z1 G,Z1 G,Z1
VI R
VII N,N2 N2 N,N2
aGene names are abbreviated from PTPR*, where * is a letter (or letter/number)
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primer). The PCR conditions used were as follows: 5 min at 95 °C, 40 cycles of 15 s
at 95 °C and 60 s at 60 °C. To confirm the formation of a single SYBR Green-
labelled PCR amplicon, each PCR reaction was followed by a three-step melting
curve analysis consisting of 15 s at 95 °C, 1 min at 60 °C, ramping up to 95 °C at 0.5
°C per sec, detecting every 0.5 s and finishing for 15 s at 95 °C, as recommended by
the manufacturer. All qPCR reactions were performed using a QuantStudio 12 K
Real-Time PCR system (Thermo Fisher, Waltham, MA); threshold cycles (CTs)
were detected by QuantStudio 12 K Flex software (Thermo Fisher, Waltham, MA).
Relative standard curves were constructed as reported41,43.
Next generation RNA sequencing and analysis. RNA extracted from the MBH
of prepubertal female rats was subjected to RNA-seq following a procedure we
recently described44. The existence of differential gene expression in the medial
basal hypothalamus during pubertal development was determined by employing
the edgeR45 analysis package. An initial trimming and adaptor removal step was
carried out using Trimmomatic46. Removal of the Illumina adapter sequences and
default filtering parameters was performed as suggested in the program’s doc-
umentation, with exception of a hard clip of the first 13 bases of the reads; this
latter step was based on FastQC visualization of the read qualities before trimming,
which indicated significantly lower read qualities in those bases as compared to the
remainder of the read. Trimmed reads that passed the Trimmomatic selection
criteria were then aligned to the rn6 build of the rat genome with Bowtie2/
Tophat247,48 using default parameters. Aligned reads were assigned to gene-level
genomic features of the Ensembl 83 annotation set using the Rsubread feature-
Counts R function with countMultiMappingReads and allowMultipleOverlaps flags
set to TRUE. Differential expression between time points was then analysed using
the generalized linear modelling approach implemented in edgeR, based on the
methods described in detail in that package’s documentation. Dispersion para-
meters for the regression model were estimated using sequential application of
edgeR’s global and tagwise methods after normalization for library size. The design
matrix used for the analysis included both indicator variables for time point and
batch effects. The latter was employed to account for any variability arising from
runs carried out on different dates and different flow cells; aside from time point
and batch effects there were no other notable covariates of interest or potential
confounders that we felt required consideration in the model. Because the model
simultaneously considers the variance of all timepoints, in addition to potential
batch effects, it effectively generates an integrated comparison of the entire data set
and obviates the need to run repeated ANOVA tests on all ~34,000 individual
genes; it also allowed us to more precisely identify differentially expressed genes
based on significance values of pairwise comparisons of time points using the
edgeR’s likelihood ratio test function glmLRT. In addition, we utilized the edgeR
voom function to produce per-sample estimates of read counts per million for
tabular visualization and to plot trends over time. Upon identification of the PTPR
family as a gene set of interest, we used qRT-PCR to verify the changes detected by
RNA-seq, and analysed the results by ANOVA followed by a multiple comparison
test (see below).
Quantitative PCR analysis. Statistical analysis of the qPCR results was performed
using Prism7 software (Graphpad Software, La jolla, CA). Differences between
groups were analysed by ONE WAY ANOVA followed by the Student-Newman-
Keuls multiple comparison test for unequal replications. RNA expression data were
normalized by dividing each individual value by the average of the PND7 group (in
the rat) or INF group (in the monkey). Data were subjected to arc–sine transfor-
mation before statistical analysis to convert them from a binomial to a normal
distribution. A P value of <0.05 was considered statistically significant.
Data availability. GWAS summary statistics have been deposited in the National
Bioscience Database Center (https://humandbs.biosciencedbc.jp/en/) under data
set identifier hum0014.v9.Men.v1and hum0014.v9.MP.v1.
The RNA-seq data was deposited in NCBI under the accession number
GSE94080.
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